Thrombosis Clinical Trials This is an RSS file. You can use it to subscribe to this data in your favourite RSS reader or to display this data on your own website or blog.

• News
• Research
• Blogs
• Podcasts
• Video
• Funding
• Alerts
• Clinical Trials
• Forums

TACE Plus Atezolizumab/Bevacizumab and I-125 Seeds Brachytherapy for HCC With Branch PVTT
Conditions:   Hepatocellular Carcinoma;   Hepatic Portal Vein Tumor Invasion;   Tumor Thrombus Interventions:   Procedure: I-125 Seeds Brachytherapy in PVTT;   Procedure: Transcatheter arterial chemoembolization;   Drug: Atezolizumab plus Bevacizumab Sponsors:   Third Affiliated Hospital, Sun Yat-Sen University;   Sun Yat-sen University;   Fifth Affiliated Hospital, Sun Yat-Sen University;   Second Affiliated Hospital of Guangzhou Medical University;   Maoming People's Hospital;   Shandong Provincial Third Hospital Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - August 9, 2023 Category: Research Source Type: clinical trials

TACE Plus Atezolizumab/Bevacizumab and I-125 Seeds Brachytherapy for HCC With Branch PVTT
Conditions:   Hepatocellular Carcinoma;   Hepatic Portal Vein Tumor Invasion;   Tumor Thrombus Interventions:   Procedure: I-125 Seeds Brachytherapy in PVTT;   Procedure: Transcatheter arterial chemoembolization;   Drug: Atezolizumab plus Bevacizumab Sponsors:   Third Affiliated Hospital, Sun Yat-Sen University;   Sun Yat-sen University;   Second Affiliated Hospital of Guangzhou Medical University;   Fifth Affiliated Hospital, Sun Yat-Sen University;   Maoming People's Hospital;   Shandong Provincial Third Hospital Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - August 9, 2023 Category: Research Source Type: clinical trials